CRISPR-engineered T cells in patients with refractory cancer
CRISPR takes first steps in humans CRISPR-Cas9 is a revolutionary gene-editing technology that offers the potential to treat diseases such as cancer, but the effects of CRISPR i...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,340
- Institution
- University of Pennsylvania
External Links
Identifiers
- ORCID
- 0000-0003-3476-4677
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.